These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16897888)

  • 21. [Hypertensiology 2007].
    Middeke M
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1368-70. PubMed ID: 17570082
    [No Abstract]   [Full Text] [Related]  

  • 22. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract]   [Full Text] [Related]  

  • 23. TGF-beta/extracellular matrix interactions in dentin matrix: a role in regulating sequestration and protection of bioactivity.
    Baker SM; Sugars RV; Wendel M; Smith AJ; Waddington RJ; Cooper PR; Sloan AJ
    Calcif Tissue Int; 2009 Jul; 85(1):66-74. PubMed ID: 19424740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Renin and the heart].
    Ural D; Cetin M
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():23-7. PubMed ID: 20019473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interactions of the growth factors and the extracellular matrix components].
    Yaoi Y
    Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1088-94. PubMed ID: 1871340
    [No Abstract]   [Full Text] [Related]  

  • 26. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory.
    Wright JW; Harding JW
    Prog Neurobiol; 2004 Mar; 72(4):263-93. PubMed ID: 15142685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early elevation of transforming growth factor-beta, decorin, and biglycan mRNA levels during cartilage matrix restoration after mild proteoglycan depletion.
    van der Kraan PM; Glansbeek HL; Vitters EL; van den Berg WB
    J Rheumatol; 1997 Mar; 24(3):543-9. PubMed ID: 9058663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparan sulphate proteoglycans and diabetic nephropathy.
    van der Woude FJ; van Det NF
    Exp Nephrol; 1997; 5(3):180-8. PubMed ID: 9208276
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulation of the chondroitin/dermatan fine structure by transforming growth factor-beta1 through effects on polymer-modifying enzymes.
    Tiedemann K; Olander B; Eklund E; Todorova L; Bengtsson M; Maccarana M; Westergren-Thorsson G; Malmström A
    Glycobiology; 2005 Dec; 15(12):1277-85. PubMed ID: 16118286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renin inhibition--benefit beyond hypertension control.
    Kher V
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 32. Aliskiren in the management of hypertension.
    Barrios V; Escobar C
    Am J Cardiovasc Drugs; 2010; 10(6):349-58. PubMed ID: 21090828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Cell Biology of Cytokines and Matrix, September 21-23 1994, Cardiff, UK.
    Gallagher J; Archer C
    Glycoconj J; 1995 Feb; 12(1):v-viii. PubMed ID: 7795407
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential expression of decorin and biglycan genes during palatogenesis in normal and retinoic acid-treated mice.
    Zhang Y; Mori T; Iseki K; Hagino S; Takaki H; Takeuchi M; Hikake T; Tase C; Murakawa M; Yokoya S; Wanaka A
    Dev Dyn; 2003 Apr; 226(4):618-26. PubMed ID: 12666199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperelongated biglycan: the surreptitious initiator of atherosclerosis.
    Little PJ; Osman N; O'Brien KD
    Curr Opin Lipidol; 2008 Oct; 19(5):448-54. PubMed ID: 18769225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decorin and its galactosaminoglycan chain: extracellular regulator of cellular function?
    Seidler DG; Dreier R
    IUBMB Life; 2008 Nov; 60(11):729-33. PubMed ID: 18800386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular matrix/growth factor interactions.
    Ruoslahti E; Yamaguchi Y; Hildebrand A; Border WA
    Cold Spring Harb Symp Quant Biol; 1992; 57():309-15. PubMed ID: 1339667
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of extracellular matrix in vascular remodeling of hypertension.
    Briones AM; Arribas SM; Salaices M
    Curr Opin Nephrol Hypertens; 2010 Mar; 19(2):187-94. PubMed ID: 20040870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Articular cartilage matrix and structure: a minireview.
    Kuettner KE; Aydelotte MB; Thonar EJ
    J Rheumatol Suppl; 1991 Feb; 27():46-8. PubMed ID: 2027129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Joint destruction and matrix metalloproteinases--regulation by pharmacologic inhibitors and growth factors].
    Matsumoto T
    Clin Calcium; 2004 Jul; 14(7):108-13. PubMed ID: 15577086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.